The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
It is the start mate.. no ramping.. reason why you would be silly to sell is we are in the perfect market.. if we were not entering a commodity supercycle or a market leader then i would be more cautious.. JLP is perfectly primed to take advantage.... news flow is exponential.. shares are being snapped up.. we should see more holdings rns
Lol, this aint a football team.. support through the good and bad.. i want as many new investors as possible.. i remember the days of no posts for weeks
We would need net earnings around 200m a year at a muliple of ten to hit the £ mark.. have a look at mikes previous messages.. we will be run rating towards 100m in 2021.2022 and this could be higher once production guidance is provided in zambia.. expected q2.. commodity prices also make this even more compelling
Based on h1 pgm production annualised.. we should produce 56k oz of pgms.. of which 60pc is platinum.. therefore 34k oz of platinum which is circa 300 an oz more than q4 2020.. that alone adds 10m additonal profit a year.. or 0.5p per share.. at a multiple if ten we should see a 5p jump in sp on the platinum rise alone.. exciting times
On bulletin board heroes.. target of 23p
https://www.share-talk.com/share-talk-bulletin-board-heroes-monday-1st-february-2021/#gs.rsvwfg
https://www.britishbulls.com/m/Default.aspx?lang=en
They usually call it right, positive to be on front page
Agreed,i worked out profit before tax of 23m for H1, operational earnings and taking away depre and finance costs from previous reports.. if we replicate H1 then FY would be 46m, EPS of 2p.. pe of 13, 26p a share.. 2022 100m target with copper